429 related articles for article (PubMed ID: 18563718)
1. Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy.
Briani C; Adami F; Cavallaro T; Taioli F; Ferrari S; Fabrizi G
Muscle Nerve; 2008 Jul; 38(1):921-3. PubMed ID: 18563718
[TBL] [Abstract][Full Text] [Related]
2. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia.
Luigetti M; Modoni A; Renna R; Silvestri G; Ricci E; Montano N; Tasca G; Papacci M; Monforte M; Conte A; Pomponi MG; Sabatelli M
Clin Neurol Neurosurg; 2010 Nov; 112(9):794-7. PubMed ID: 20537790
[TBL] [Abstract][Full Text] [Related]
3. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
4. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic clustering in MPZ mutations.
Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
[TBL] [Abstract][Full Text] [Related]
6. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
8. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the myelin protein zero gene.
Kochański A; Kabzińska D; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
Eur J Paediatr Neurol; 2004; 8(4):221-4. PubMed ID: 15261887
[TBL] [Abstract][Full Text] [Related]
9. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
[TBL] [Abstract][Full Text] [Related]
10. [Two families of Charcot-Marie-Tooth disease with Adie's pupil, axonal neuropahy and the Thr124Met mutation in the peripheral myelin protein zero gene].
Misu K; Yoshihara T; Yamamoto M; Hattori N; Nagamatu M; Mukai E; Takegami T; Sobue G
Rinsho Shinkeigaku; 2000 Feb; 40(2):149-54. PubMed ID: 10835936
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of hereditary neuropathies.
Chance PF
Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
[TBL] [Abstract][Full Text] [Related]
12. [Clinical phenotype of Charcot-Marie-Tooth disease (CMT) and familial amyloid polyneuropathy (FAP)].
Sobue G
Rinsho Shinkeigaku; 2003 Nov; 43(11):769-74. PubMed ID: 15152460
[TBL] [Abstract][Full Text] [Related]
13. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
14. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
Nowakowski A; Kochański A
Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
[TBL] [Abstract][Full Text] [Related]
15. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
Sabet A; Li J; Ghandour K; Pu Q; Wu X; Kamholz J; Shy ME; Cambi F
Neurology; 2006 Oct; 67(7):1141-6. PubMed ID: 17030746
[TBL] [Abstract][Full Text] [Related]
16. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.
Laurà M; Milani M; Morbin M; Moggio M; Ripolone M; Jann S; Scaioli V; Taroni F; Pareyson D
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1263-6. PubMed ID: 17940173
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
Eggers SD; Keswani SC; Melli G; Cornblath DR
Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.
Fabrizi GM; Tamburin S; Cavallaro T; Cabrini I; Ferrarini M; Taioli F; Magrinelli F; Zanette G
Clin Neurophysiol; 2018 Jan; 129(1):21-32. PubMed ID: 29136549
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of hereditary neuropathy: genotype-phenotype correlation].
Nakagawa M; Takashima H
Rinsho Byori; 2003 Jun; 51(6):536-43. PubMed ID: 12884740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
